Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
InnoCan Pharma: Multi-Milliarden-Wert in diesem Pennystock?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
58 Leser
Artikel bewerten:
(0)

Global Pharmacy Automation Market 2017 - Forecast to 2022 - Research and Markets

DUBLIN, May 8, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Pharmacy Automation Market by Product (Medication Dispensing System (Robot, Carousel),Packaging & Labeling System (Unit Dose, Multi Dose), Tabletop Counter, Storage System),End User (Inpatient, Outpatient, Retail Pharmacy) - Global Forecast to 2022" report to their offering.

Research and Markets Logo

The global pharmacy automation market is projected to reach USD 5.38 Billion by 2022, at a CAGR of 8.2% from 2017 to 2022. The market growth can be attributed to a number of factors such as the growing need to minimize medication errors, rapid decentralization of pharmacies, changing population demographics, and rising labor costs.

Automated medication dispensing systems accounted for the largest share of the pharmacy automation market in 2016. Decentralized automated dispensing system is expected to be the fastest growing product segment in the automated medication dispensing systems market during the forecast period. This is mainly attributed to the rising demand for accurate and timely dispensing of a treatment regimen and the need for avoiding dispensing errors associated with the type and dosage of commonly prescribed medication.

Retail pharmacies is expected to be the fastest growing end user segment in the pharmacy automation market during the forecast period. Rising number of retail pharmacies and increasing workload on pharmacists are the major factors driving the rising adoption of pharmacy automation systems in retail pharmacies.

In 2016, North America accounted for the largest share of the global pharmacy automation market, largely attributed to the increasing number of drug prescriptions at pharmacies resulting from growth in the aging population. Furthermore, growth in insurance coverage in the U.S. has increased the burden on the country's healthcare system, which has highlighted the need for improving efficiency and management of work in North America. With the rapid rise in the number of patients, demand for quality care, and effective upgradation of the healthcare IT infrastructure is expected to have a positive impact on the demand for pharmacy automation systems market in APAC and Latin America.

The major players in the pharmacy automation market are Becton, Dickinson, and Company (U.S.), Omnicell, Inc. (U.S.), Cerner Corporation (U.S.), Capsa Healthcare (U.S.), Parata Systems LLC (U.S), Baxter International, Inc. (U.S.), ScriptPro LLC (U.S.), KUKA AG (Germany), TCGRx Pharmacy Workflow Solutions (U.S.), RxSafe, LLC (U.S.), ARxIUM Inc. (U.S.) and Talyst systems LLC. (U.S.).

Market Dynamics

Drivers

  • Growing Need to Minimize Medication Errors
  • Decentralization of Pharmacies
  • Rising Geriatric Population
  • Rising Labor Cost

Restraints

  • Reluctance to Adopt Pharmacy Automation Systems

Opportunities

  • Increasing Awareness Among Pharmacists
  • Emerging Markets
  • Healthcare Cost-Reduction Measures

Challenges

  • Stringent Regulatory Procedures

For more information about this report visit http://www.researchandmarkets.com/research/dzthk2/pharmacy


Media Contact:


Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716



Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.